Sanofi Winthrop Industrie

Aramon, FranceFEI 3002808341API manufacture registered

Sanofi Winthrop Industrie is a drug establishment in Aramon, France, registered with the US FDA under FEI 3002808341. Its registered operations are: Analytical testing, API manufacture. 9 EU/UK GMP certificates are matched to this site, 2 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingAPI manufacture

GMP documents matched to this site (9)

DocumentAuthorityInspectionSource
26MPP015HVFR01
GMP certificate
Competent authority of France19 Jun 2026
within 3-year review window
EudraGMDP
26MPP015HVFR02
GMP certificate
Competent authority of France19 Jun 2026
within 3-year review window
EudraGMDP
23MPP023HFR04
GMP certificate
Competent authority of France10 Mar 2023
outside 3-year review window
EudraGMDP
23MPP023HFR03
GMP certificate
Competent authority of France10 Mar 2023
outside 3-year review window
EudraGMDP
22MB063HFR03
GMP certificate
Competent authority of France9 Dec 2022
outside 3-year review window
EudraGMDP
22MB063HFR02
GMP certificate
Competent authority of France9 Dec 2022
outside 3-year review window
EudraGMDP
21MPP092HFR02
GMP certificate
Competent authority of France17 Dec 2021
outside 3-year review window
EudraGMDP
21MPP092VFR02
GMP certificate
Competent authority of France17 Dec 2021
outside 3-year review window
EudraGMDP
21MPP092HVFR02
GMP certificate
Competent authority of France17 Dec 2021
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.

Other sites registered by the same company